UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Br J Ophthalmol. 2019 Feb;103(2):233-237. doi: 10.1136/bjophthalmol-2017-311392. Epub 2018 Apr 29.
Carbonic anhydrase inhibitors (CAIs) are frequently used as an initial step to treat retinitis pigmentosa-associated cystoid macular oedema (RP-CMO). Interestingly, it has been postulated that CAIs might reduce outer nuclear layer (ONL) fluid more effectively than inner nuclear layer (INL) fluid due to better access to retinal pigment epithelium basolateral membrane than neurosensory retina. This retrospective cohort study explores if an association between spatial distribution of cystoid spaces in RP-CMO and CAI response exists.
Two independent graders reviewed pretreatment and post-treatment optical coherence tomography (OCT) images of 25 patients (43 eyes) initiated on topical and/or oral CAIs between January 2013 and December 2014. Documentation included the presence/absence of fluid (and layer(s) involved), external limiting membrane, epiretinal membrane (ERM), vitreomacular adhesion/traction, lamellar/full-thickness macular hole and central macular thickness (CMT)/volume.
INL fluid was found in all study eyes. All 13 'responders' (at least 11% reduction of CMT after treatment) demonstrated pretreatment ONL fluid. In seven patients (four responders and three non-responders), complete clearance of ONL fluid was achieved despite persistence of INL fluid. ERM presence was similar in responders and non-responders.
In this study, INL fluid was found to be the most common spatial distribution of RP-CMO. However, patients who were classed as a 'responder' to CAI treatment all demonstrated coexisting ONL fluid on their pretreatment OCT scans. This may be explained by CAIs having better access to retinal pigment epithelium basolateral membrane than neurosensory retina. Our study also suggests a minimal impact on response to CAIs by ERM.
碳酸酐酶抑制剂(CAI)常被用作治疗色素性视网膜炎相关性囊样黄斑水肿(RP-CMO)的初始治疗方法。有趣的是,有人假设 CAI 可能更有效地减少外核层(ONL)液体,而不是内核层(INL)液体,因为它们比神经感觉视网膜更容易进入视网膜色素上皮基底外侧膜。这项回顾性队列研究探讨了 RP-CMO 中囊样空间的空间分布与 CAI 反应之间是否存在关联。
两位独立的评分者回顾了 2013 年 1 月至 2014 年 12 月期间接受局部和/或口服 CAI 治疗的 25 名患者(43 只眼)的治疗前和治疗后光学相干断层扫描(OCT)图像。记录内容包括液体(涉及的层)的存在/不存在、外界膜、内界膜、视网膜前膜(ERM)、玻璃体黄斑粘连/牵引、板层/全层黄斑裂孔和中心黄斑厚度(CMT)/容积。
所有研究眼均存在 INL 液体。所有 13 名“应答者”(治疗后 CMT 减少至少 11%)均存在预处理 ONL 液体。在七名患者(四名应答者和三名非应答者)中,尽管 INL 液体持续存在,但 ONL 液体完全清除。应答者和非应答者的 ERM 存在情况相似。
在这项研究中,INL 液体被发现是 RP-CMO 最常见的空间分布。然而,被归类为 CAI 治疗“应答者”的患者在其治疗前的 OCT 扫描中均显示出共存的 ONL 液体。这可能是因为 CAI 比神经感觉视网膜更容易进入视网膜色素上皮基底外侧膜。我们的研究还表明,ERM 对 CAI 反应的影响很小。